Cumulus Neuroscience, a leading innovator in brain health technology for clinical trials, today announced the publication of ...

Lysoway Therapeutics, Inc., a biotechnology company advancing structure-guided small-molecule modulators of lysosomal ion channels to treat age-related neurodegeneration, today announced that its lead ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

San Diego Zoo Wildlife Alliance has announced the election of Rolf Benirschke as the new chairman of its Board of Trustees. Benirschke, who previously served as vice chairman, succeeds Steven S.

MapLight Therapeutics, Inc. ("MapLight") (Nasdaq: MPLT) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

The analyses of progression-free survival (PFS) and overall survival (OS) remain on track for late Q1 2026 in the ongoing Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) ...

Currently, Kyocera's technology enables aerial images whose focal positions vary by color. In the future, increasing the ...

Ad hoc announcement pursuant to Art. 53 LR Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is ...

Ad hoc announcement pursuant to Art. 53 LR EP4615820 "Crystalline Forms of Evenamide" is expected to extend asset exclusivity in EU into 2044 Evenamide is currently being investigated in Newron's ...

A joint research team from the Institute of Metal Research (IMR) of the Chinese Academy of Sciences and the Songshan Lake Materials Laboratory has achieved precise control and real-time observation of ...